200 related articles for article (PubMed ID: 21541316)
1. Crystal structure of the HIV-2 neutralizing Fab fragment 7C8 with high specificity to the V3 region of gp125.
Uchtenhagen H; Friemann R; Raszewski G; Spetz AL; Nilsson L; Achour A
PLoS One; 2011 Apr; 6(4):e18767. PubMed ID: 21541316
[TBL] [Abstract][Full Text] [Related]
2. Production, purification, crystallization and preliminary X-ray diffraction analysis of the HIV-2-neutralizing V3 loop-specific Fab fragment 7C8.
Uchtenhagen H; Sourial S; Friemann R; Ehnlund M; Spetz AL; Harris RA; Madhurantakam C; Achour A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):705-8. PubMed ID: 19574645
[TBL] [Abstract][Full Text] [Related]
3. HIV-2 neutralization by intact V3-specific Fab fragments.
Sourial S; Nilsson C
Virol J; 2008 Aug; 5():96. PubMed ID: 18706111
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the V1/V2 region does not increase the accessibility of the V3 region of recombinant gp125.
Sourial S; Nilsson C; Wärnmark A; Achour A; Harris RA
Curr HIV Res; 2006 Apr; 4(2):229-37. PubMed ID: 16611061
[TBL] [Abstract][Full Text] [Related]
5. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
[TBL] [Abstract][Full Text] [Related]
7. The Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged Groups.
Haji-Ghassemi O; Müller-Loennies S; Rodriguez T; Brade L; Grimmecke HD; Brade H; Evans SV
J Biol Chem; 2016 May; 291(19):10104-18. PubMed ID: 26933033
[TBL] [Abstract][Full Text] [Related]
8. Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization.
Bell CH; Pantophlet R; Schiefner A; Cavacini LA; Stanfield RL; Burton DR; Wilson IA
J Mol Biol; 2008 Jan; 375(4):969-78. PubMed ID: 18068724
[TBL] [Abstract][Full Text] [Related]
9. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24.
Monaco-Malbet S; Berthet-Colominas C; Novelli A; Battaï N; Piga N; Cheynet V; Mallet F; Cusack S
Structure; 2000 Oct; 8(10):1069-77. PubMed ID: 11080628
[TBL] [Abstract][Full Text] [Related]
10. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
Wu X; Zhou T; Zhu J; Zhang B; Georgiev I; Wang C; Chen X; Longo NS; Louder M; McKee K; O'Dell S; Perfetto S; Schmidt SD; Shi W; Wu L; Yang Y; Yang ZY; Yang Z; Zhang Z; Bonsignori M; Crump JA; Kapiga SH; Sam NE; Haynes BF; Simek M; Burton DR; Koff WC; Doria-Rose NA; Connors M; ; Mullikin JC; Nabel GJ; Roederer M; Shapiro L; Kwong PD; Mascola JR
Science; 2011 Sep; 333(6049):1593-602. PubMed ID: 21835983
[TBL] [Abstract][Full Text] [Related]
11. Human anti-V3 HIV-1 monoclonal antibodies encoded by the VH5-51/VL lambda genes define a conserved antigenic structure.
Gorny MK; Sampson J; Li H; Jiang X; Totrov M; Wang XH; Williams C; O'Neal T; Volsky B; Li L; Cardozo T; Nyambi P; Zolla-Pazner S; Kong XP
PLoS One; 2011; 6(12):e27780. PubMed ID: 22164215
[TBL] [Abstract][Full Text] [Related]
12. Human neutralizing human immunodeficiency virus type 2-specific Fab molecules generated by phage display.
Björling E; von Garrelts E; Mörner A; Ehnlund M; Persson MAA
J Gen Virol; 1999 Aug; 80 ( Pt 8)():1987-1993. PubMed ID: 10466795
[TBL] [Abstract][Full Text] [Related]
13. Identification of B-cell antigenic sites on HIV-2 gp125.
Mannervik M; Putkonen P; Rudén U; Kent KA; Norrby E; Wahren B; Broliden PA
J Acquir Immune Defic Syndr (1988); 1992; 5(2):177-87. PubMed ID: 1370692
[TBL] [Abstract][Full Text] [Related]
14. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.
Cale EM; Gorman J; Radakovich NA; Crooks ET; Osawa K; Tong T; Li J; Nagarajan R; Ozorowski G; Ambrozak DR; Asokan M; Bailer RT; Bennici AK; Chen X; Doria-Rose NA; Druz A; Feng Y; Joyce MG; Louder MK; O'Dell S; Oliver C; Pancera M; Connors M; Hope TJ; Kepler TB; Wyatt RT; Ward AB; Georgiev IS; Kwong PD; Mascola JR; Binley JM
Immunity; 2017 May; 46(5):777-791.e10. PubMed ID: 28514685
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the principal neutralization site of HIV-1.
Ghiara JB; Stura EA; Stanfield RL; Profy AT; Wilson IA
Science; 1994 Apr; 264(5155):82-5. PubMed ID: 7511253
[TBL] [Abstract][Full Text] [Related]
17. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
[TBL] [Abstract][Full Text] [Related]
18. Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1.
He XM; Rüker F; Casale E; Carter DC
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7154-8. PubMed ID: 1496010
[TBL] [Abstract][Full Text] [Related]
19. Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody.
Karpusas M; Lucci J; Ferrant J; Benjamin C; Taylor FR; Strauch K; Garber E; Hsu YM
Structure; 2001 Apr; 9(4):321-9. PubMed ID: 11525169
[TBL] [Abstract][Full Text] [Related]
20. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
